Navitas Life Sciences

Drug meets Device  
Successfully integrating Combination Products 
and Medical Devices into a pharmaceutical environment

New combination product and medical device legislation increasingly focuses on safety, oversight and regulatory compliance. As more and more pharmaceutical companies include combination products or medical devices in their portfolio, the existing pharmaceutical governance models, processes and supporting databases are tested to their limits. This is becoming increasingly evident in regulatory inspection findings. 

At Navitas Life Sciences, we believe that at least three initiatives are key:

  • Proactive cross-functional governance and organisation
  • Aligned drug and device processes
  • Forward-looking UDI and IDMP integration
Please complete form to download PDF
First Name
Last Name
Business Email
Company
Job Title
Country
By submitting this form, I agree to receive email communications from Navitas Life Sciences. View Navitas Life Sciences' Privacy Policy

© 2019 Navitas Life Sciences | A TAKE Solutions Enterprise  | privacy policy